Monday June 26th 2017

Archive for November, 2010

Feeling liberated

Feeling liberated

With the help of her mother, Wilma Carberry slides off her wheelchair and onto the seat of an exercise bicycle. Her feet locked tightly into the pedals, Carberry pushes forward to make the wheels turn. After a few awkward turns, she gets into a steady groove, legs chugging [Read More]

‘Liberation’ from disease

‘Liberation’ from disease

After years of praying, Sharon Krar got her miracle. The Grimsby resident has gained a new lease on life after receiving what she calls the cure to her multiple sclerosis. Diagnosed with the debilitating disease 25 years ago, the 49-year-old mother of three has begun [Read More]

MS sufferers continue to look for out-of-country solutions

MS sufferers continue to look for out-of-country solutions

Brad Hinton has had to amass some credit card debt and his mother even decided to sell her rare art collection to get her son to Mexico in hopes he could fight his disabling disease. Multiple sclerosis patient Brad Hinton of Dorchester travelled to Mexico in order to [Read More]

 Page 1 of 20  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]